Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III, L.P. | 1,744,373 5.900% | 816,667 (+88.03%) | Filing |
| 2023-09-21 4:15 pm Purchase | 2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III, L.P. | 927,706 6.300% | 927,706 (New Position) | Filing |